Ordering RecommendationRecommendations when to order or not order the test. May include related or preferred tests.
Useful as a tumor marker for squamous cell carcinomas of the head and neck, uterine cervix, lung, vulva, and esophagus.
MnemonicUnique test identifier.
SCC S
MethodologyProcess(es) used to perform the test.
Immunofluorescence
PerformedDays of the week the test is performed.
Tue
ReportedExpected turnaround time for a result, beginning when ARUP has received the specimen.
1-8 days
New York DOH Approval StatusIndicates test has been approved by the New York State Department of Health.
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
Specimen Required
Patient Preparation
Collect
Serum separator tube or plain red.
Specimen Preparation
Allow specimen to clot completely at room temperature. Separate serum from cells ASAP or within 2 hours of collection. Transfer 2 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Storage/Transport Temperature
Frozen.
Unacceptable Conditions
Specimens exposed to repeated freeze/thaw cycles.
Remarks
Stability
After separation from cells: Ambient: 48 hours; Refrigerated: 14 days; Frozen: 2 months
Reference IntervalNormal range/expected value(s) for a specific disease state. May also include abnormal ranges.
0.0-1.7 ng/mL
Interpretive DataBackground information for test. May include disease information, patient result explanation, recommendations, details of testing, associated diseases, explanation of possible patient results.
This test is performed using the BRAHMS SCC Kryptor kit. Results obtained with different assay methods or kits cannot be used interchangeably. SCC Antigen levels alone should not be interpreted as evidence of the presence or absence of malignant disease. In patients with known or expected cancer, other tests and procedures must be considered for diagnosis and patient management. Elevated concentrations may also occur in benign conditions such as gynecological diseases, inflammatory lung disease, and liver or renal insufficiency.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
CPT CodesThe American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
AliasesOther names that describe the test. Synonyms.
Chat
Feedback
